Adjunct Minocyline in Treatment-resistant Depression

NCT02456948 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

168

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Minocycline
DRUG: Placebo

Sponsor

Charite University, Berlin, Germany